Biosynthesis of antifungal and antibacterial polyketides by Burkholderia gladioli in coculture with Rhizopus microsporus

Mycoses

Volumn 57, Issue s3, 2014, Pages 48-55

  Ross, Claudia ^a   Opel, Viktoria ^a   Scherlach, Kirstin ^a   Hertweck, Christian ^a,b  

^a HANS KNÖLL INSTITUTE   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Bongkrekic acid; Enacyloxin; Genome mining; Mucorales; Natural products; Toxoflavin

Indexed keywords

BURKHOLDERIA GLADIOLI; MUCORALES; RHIZOPUS MICROSPORUS;

EID: 84913620000     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12246     Document Type: Article

References (57)

1. Scherlach K, Graupner K, Hertweck C. Molecular bacteria-fungi interactions: effects on environment, food, and medicine. Annu Rev Microbiol 2013; 67: 375-97.
2. Frey-Klett P, Burlinson P, Deveau A, Barret M, Tarkka M, Sarniguet A. Bacterial-fungal interactions: hyphens between agricultural, clinical, environmental, and food microbiologists. Microbiol Mol Biol Rev 2011; 75: 583-609.
3. Kobayashi DY, Crouch JA. Bacterial/Fungal interactions: from pathogens to mutualistic endosymbionts. Annu Rev Phytopathol 2009; 47: 63-82.
4. Lackner G, Hertweck C. Impact of endofungal bacteria on infection biology, food safety, and drug development. PLoS Pathog 2011; 7: e1002096.
5. Partida-Martinez LP, Bandemer S, Ruchel R, Dannaoui E, Hertweck C. Lack of evidence of endosymbiotic toxin-producing bacteria in clinical Rhizopus isolates. Mycoses 2008; 51: 266-9.
6. Ibrahim AS, Gebremariam T, Liu M et al. Bacterial endosymbiosis is widely present among zygomycetes but does not contribute to the pathogenesis of mucormycosis. J Infect Dis 2008; 198: 1083-90.
7. Walther G, Pawlowska J, Alastruey-Izquierdo A et al. DNA barcoding in Mucorales: an inventory of biodiversity. Persoonia 2013; 30: 11-47.
8. Hachmeister KA, Fung DY. Tempeh: a mold-modified indigenous fermented food made from soybeans and/or cereal grains. Crit Rev Microbiol 1993; 19: 137-88.
9. Tintelnot K, Nitsche B. Rhizopus oligosporus as a cause of mucormycosis in man. Mycoses 1989; 32: 115-8.
10. Buckle KA, Kartadarma EK. Inhibition of bongkrek acid and toxoflavin production in tempe bongkrek containing Pseudomonas cocovenenans. J Appl Bacteriol 1990; 68: 571-6.
11. Adams MR, Moss MO. Food Microbiology. Cambridge: Royal Society of Chemistry, 2008.
12. Garcia RA, Hotchkiss JH, Steinkraus KH. The effect of lipids on bongkrekic (Bongkrek) acid toxin production by Burkholderia cocovenenans in coconut media. Food Addit Contam 1999; 16: 63-69.
13. Coenye T, Holmes B, Kersters K, Govan JR, Vandamme P. Burkholderia cocovenenans (van Damme et al. 1960) Gillis et al. 1995 and Burkholderia vandii Urakami et al. 1994 are junior synonyms of Burkholderia gladioli (Severini 1913) Yabuuchi et al. 1993 and Burkholderia plantarii (Azegami et al. 1987) Urakami et al. 1994, respectively. Int J Syst Bacteriol 1999; 49(Pt 1): 37-42.
14. de Bruijn J, Frost DJ, Nugteren DH, Gaudemer A, Lijmbach GWM, Cox HC. The structure of bongkrekic acid. Tetrahedron 1973; 29: 1541-7.
15. Henderson PJ, Lardy HA. Bongkrekic acid. An inhibitor of the adenine nucleotide translocase of mitochondria. J Biol Chem 1970; 245: 1319-26.
16. Henderson PJ, Lardy HA, Dorschner E. Factors affecting the inhibition of adenine nucleotide translocase by bongkrekic acid. Biochemistry 1970; 9: 3453-7.
17. Rohm B, Scherlach K, Hertweck C. Biosynthesis of the mitochondrial adenine nucleotide translocase (ATPase) inhibitor bongkrekic acid in Burkholderia gladioli. Org Biomol Chem 2010; 8: 1520-2.
18. Moebius N, Ross C, Scherlach K, Rohm B, Roth M, Hertweck C. Biosynthesis of the respiratory toxin bongkrekic acid in the pathogenic bacterium Burkholderia gladioli. Chem Biol 2012; 19: 1164-674.
19. Latuasan HE, Berends W. On the origin of the toxicity of toxoflavin. Biochim Biophys Acta 1961; 52: 502-8.
20. Franke J, Ishida K, Hertweck C. Genomics-driven discovery of burkholderic acid, a noncanonical, cryptic polyketide from human pathogenic Burkholderia species. Angew Chem Int Ed Engl 2012; 51: 11611-5.
21. Lackner G, Moebius N, Partida-Martinez L, Hertweck C. Complete genome sequence of Burkholderia rhizoxinica, an endosymbiont of Rhizopus microsporus. J Bacteriol 2011; 193: 783-4.
22. Lackner G, Moebius N, Partida-Martinez LP, Boland S, Hertweck C. Evolution of an endofungal lifestyle: deductions from the Burkholderia rhizoxinica genome. BMC Genomics 2011; 12: 210.
23. Franke J, Ishida K, Ishida-Ito M, Hertweck C. Nitro versus hydroxamate in siderophores of pathogenic bacteria: effect of missing hydroxylamine protection in malleobactin biosynthesis. Angew Chem Int Ed Engl 2013; 52: 8271-5.
24. Biggins JB, Gleber CD, Brady SF. Acyldepsipeptide HDAC inhibitor production induced in Burkholderia thailandensis. Org Lett 2011; 13: 1536-9.
25. Biggins JB, Liu X, Feng Z, Brady SF. Metabolites from the induced expression of cryptic single operons found in the genome of Burkholderia pseudomallei. J Am Chem Soc 2011; 133: 1638-41.
26. Biggins JB, Ternei MA, Brady SF. Malleilactone, a polyketide synthase-derived virulence factor encoded by the cryptic secondary metabolome of Burkholderia pseudomallei group pathogens. J Am Chem Soc 2012; 134: 13192-5.
27. Wang C, Henkes LM, Doughty LB et al. Thailandepsins: bacterial products with potent histone deacetylase inhibitory activities and broad-spectrum antiproliferative activities. J Nat Prod 2011; 74: 2031-8.
28. Liu X, Biswas S, Berg MG et al. Genomics-guided discovery of thailanstatins A, B, and C as pre-mRNA splicing inhibitors and antiproliferative agents from Burkholderia thailandensis MSMB43. J Nat Prod 2013; 76: 685-93.
29. Scherlach K, Busch B, Lackner G, Paszkowski U, Hertweck C. Symbiotic cooperation in the biosynthesis of a phytotoxin. Angew Chem Int Ed 2012; 51: 9615-8.
30. Partida-Martinez LP, Hertweck C. Pathogenic fungus harbours endosymbiotic bacteria for toxin production. Nature 2005; 437: 884-8.
31. Partida-Martinez LP, Groth I, Schmitt I, Richter W, Roth M, Hertweck C. Burkholderia rhizoxinica sp. nov. and Burkholderia endofungorum sp. nov., bacterial endosymbionts of the plant-pathogenic fungus Rhizopus microsporus. Int J Syst Evol Microbiol 2007; 57: 2583-90.
32. Scherlach K, Partida-Martinez LP, Dahse HM, Hertweck C. Antimitotic rhizoxin derivatives from a cultured bacterial endosymbiont of the rice pathogenic fungus Rhizopus microsporus. J Am Chem Soc 2006; 128: 11529-36.
33. Partida-Martinez LP, de Looss CF, Ishida K et al. Rhizonin, the first mycotoxin isolated from Zygomycota, is not a fungal metabolite, but produced by bacterial endosymbionts. Appl Environ Microbiol 2007; 73: 793-7.
34. Winter JM, Behnken S, Hertweck C. Genomics-inspired discovery of natural products. Curr Opin Chem Biol 2011; 15: 22-31.
35. Scherlach K, Hertweck C. Triggering cryptic natural product biosynthesis in microorganisms. Org Biomol Chem 2009; 7: 1753-60.
36. Medema MH, Blin K, Cimermancic P et al. antiSMASH: rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences. Nucleic Acids Res 2011; 39: W339-46.
37. Blin K, Medema MH, Kazempour D et al. antiSMASH 2.0 - a versatile platform for genome mining of secondary metabolite producers. Nucleic Acids Res 2013; 41: W204-12.
38. Bachmann BO, Ravel J. Chapter 8. Methods for in silico prediction of microbial polyketide and nonribosomal peptide biosynthetic pathways from DNA sequence data. Methods Enzymol 2009; 458: 181-217.
39. Box SJ, Brown AG, Gilpin ML, Gwynn MN, Spear SR. MM 42842, a new member of the monobactam family produced by Pseudomonas cocovenenans. II. Production, isolation and properties of MM 42842. J Antibiot 1988; 41: 7-12.
40. Abdou R, Scherlach K, Dahse HM, Sattler I, Hertweck C. Botryorhodines A-D, antifungal and cytotoxic depsidones from Botryosphaeria rhodina, an endophyte of the medicinal plant Bidens pilosa. Phytochemistry 2009; 71: 110-6.
41. Suzuki F, Sawada H, Azegami K, Tsuchiya K. Molecular characterization of the tox operon involved in toxoflavin biosynthesis of Burkholderia glumae. J Gen Plant Pathol 2004; 70: 97-107.
42. Kim J, Kim JG, Kang Y et al. Quorum sensing and the LysR-type transcriptional activator ToxR regulate toxoflavin biosynthesis and transport in Burkholderia glumae. Mol Microbiol 2004; 54: 921-34.
43. Ham JH, Melanson RA, Rush MC. Burkholderia glumae: next major pathogen of rice? Mol Plant Pathol 2011; 12: 329-39.
44. Chen R, Barphagha IK, Karki HS, Ham JH. Dissection of quorum-sensing genes in Burkholderia glumae reveals non-canonical regulation and the new regulatory gene tofM for toxoflavin production. PLoS ONE 2012; 7: e52150.
45. Schroeckh V, Scherlach K, Nutzmann HW et al. Intimate bacterial-fungal interaction triggers biosynthesis of archetypal polyketides in Aspergillus nidulans. Proc Natl Acad Sci USA 2009; 106: 14558-63.
46. Lincke T, Behnken S, Ishida K, Roth M, Hertweck C. Closthioamide: an unprecedented polythioamide antibiotic from the strictly anaerobic bacterium Clostridium cellulolyticum. Angew Chem Int Ed Engl 2010; 49: 2011-3.
47. Konig CC, Scherlach K, Schroeckh V et al. Bacterium induces cryptic meroterpenoid pathway in the pathogenic fungus Aspergillus fumigatus. Chembiochem 2013; 14: 938-42.
48. Han B, Kiers JL, Nout RM. Solid-substrate fermentation of soybeans with Rhizopus spp.: comparison of discontinuous rotation with stationary bed fermentation. J Biosci Bioeng 1999; 88: 205-9.
49. Cetin R, Krab IM, Anborgh PH et al. Enacyloxin IIa, an inhibitor of protein biosynthesis that acts on elongation factor Tu and the ribosome. EMBO J 1996; 15: 2604-11.
50. Watanabe T, Sugiyama T, Takahashi M et al. New polyenic antibiotics active against gram-positive and gram-negative bacteria. IV. Structural elucidation of enacyloxin IIa. J Antibiot 1992; 45: 470-5.
51. Watanabe T, Suzuki T, Izaki K. New polyenic antibiotics active against gram-positive and gram-negative bacteria. V. Mode of action of enacyloxin IIa. J Antibiot 1991; 44: 1457-9.
52. Watanabe T, Shima J, Izaki K, Sugiyama T. New polyenic antibiotics active against gram-positive and gram-negative bacteria. VII. Isolation and structure of enacyloxin IVa, a possible biosynthetic intermediate of enacyloxin IIa. J Antibiot 1992; 45: 575-6.
53. Mahenthiralingam E, Song L, Sass A et al. Enacyloxins are products of an unusual hybrid modular polyketide synthase encoded by a cryptic Burkholderia ambifaria genomic island. Chem Biol 2011; 18: 665-77.
54. Parmeggiani A, Krab IM, Watanabe T et al. Enacyloxin IIa pinpoints a binding pocket of elongation factor Tu for development of novel antibiotics. J Biol Chem 2006; 281: 2893-900.
55. Parmeggiani A, Nissen P. Elongation factor Tu-targeted antibiotics: four different structures, two mechanisms of action. FEBS Lett 2006; 580: 4576-81.
56. Subik J, Behun M. Effect of bongkrekic acid on growth and metabolism of filamentous fungi. Arch Microbiol 1994; 97: 81-88.
57. Scherlach K, Lackner G, Graupner K, Pidot S, Bretschneider T, Hertweck C. Biosynthesis and mass spectrometric imaging of tolaasin, the virulence factor of brown blotch mushroom disease. Chembiochem 2013; 14: 2439-43.